Several compounds, such as wogonin, have been used to inhibit NRF2 expression in cisplatin-resistant cells, reducing NRF2 protein and reduced-glutathione (GSH) levels and promoting cell apoptosis of cancer cells without affecting healthy ones [62]. This evidence concerns the gene NFE2L2 and cancer.